GE HealthCare, Mayo Clinic launch theranostics trial in Minnesota

GE HealthCare and Mayo Clinic begin a new theranostics clinical trial in Minnesota.

• The trial is a collaboration between GE HealthCare and Mayo Clinic in Minnesota.
• Theranostics pairs diagnostic imaging with targeted radionuclide therapy.
• No further details on the investigational agent or enrollment were reported in the source.

RadPigeon summaries are original and for information only. They are not clinical advice.